The landscape of dementia analysis has evolved dramatically with the advent of innovative biomarkers, together with amyloid PET scans, tau imaging, and blood-based tests that will detect Alzheimer's pathology several years right before symptoms emerge. Whilst these technological advancements stand for remarkable progress in knowing neurodegenerativ